Introduction {#Sec1}
============

Recently, the surgical technique for pancreatectomy has improved; however, pancreatectomy is associated with many complications postsurgery \[[@CR1]--[@CR4]\]. Although the frequency of postpancreatectomy hemorrhage (PPH) is not high, it results in severe adverse outcomes. The incidence rate of PPH and the mortality rate following PPH have been reported to be 3--16% and 16--36%, respectively \[[@CR4]--[@CR12]\]. The International Study Group on Pancreatic Surgery (ISGPS) defined PPH in 2007 \[[@CR13]\]. Some studies have reported that postoperative pancreatic fistula (POPF), postoperative bile leakage, and postoperative abdominal infection are risk factors for PPH \[[@CR5]--[@CR12]\]. Although this information is useful, it includes intraoperative and postoperative factors that can only be known after surgery. Other studies reported that male sex, high body mass index (BMI), and low serum albumin (Alb) levels, which are preoperative factors, are associated with PPH \[[@CR8], [@CR10], [@CR12], [@CR14]\]. However, the preoperative risk factors for PPH have not been fully elucidated yet. Therefore, the aim of this study was to clarify the preoperative risk factors for PPH.

Material and methods {#Sec2}
====================

Between 2005 and 2018, 1169 patients underwent pancreatectomy at the Department of Surgery, Institute of Gastroenterology, Tokyo Woman's Medical University. Parameters that were evaluated included the incidence, outcomes, time of onset, location, severity, grade, and risk factors of PPH. Clinical data that were collected and examined included age; sex; preoperative BMI; white blood cell (WBC) count; serum levels of Alb, C-reactive protein (CRP), and hemoglobin A1c (HbA1c); preoperative drainage for obstructive jaundice; preoperative treatment (chemotherapy or chemoradiotherapy); operative procedure, duration of surgery; amount of intraoperative blood loss; vascular resection; pancreatojejunostomy (PJ) anastomosis method; falciform ligament wrapping of the gastroduodenal artery (GDA) stump; clipping of the GDA stump; PJ stent; pathological tissue type; pancreatic fistula; delayed gastric emptying (DGE); and postoperative bile leakage. The significant factors identified by multivariate analysis to cause PPH were defined as risk factors for PPH. The risk score was calculated, with 1 point assigned to each risk factor, and the incidence of PPH was examined for each risk score number.

The patients' characteristics for all pancreatectomies are shown in Supplemental Table [1](#MOESM1){ref-type="media"}. Six hundred fifty-five patients (56%) were men; the median preoperative BMI level was 21.5 kg/m^2^ (range 14.3--36.8 kg/m^2^); 421 patients (36%) had diabetes mellitus (DM); 675 patients (57%) underwent pancreatoduodenectomy (PD); 211 patients (18%) had POPF grade B (15.6%, 182 patients) or C (2.5%, 29 patients); 279 (24%) patients underwent HDL wrapping of the GDA stump; none of the patients with omental grafts underwent GDA stump wrapping, and all patients underwent vascularized graft placement of the GDA stump using the falciform ligament; 26 (2%) patients underwent clipping of the GDA stump.

Definitions {#Sec3}
===========

PPH, POPF, and DGE {#Sec4}
------------------

The PPH, POPF, and DGE grades were defined using ISGPS guidelines \[[@CR13], [@CR15], [@CR16]\] and categorized into 3 (grades A, B, and C). Since the grade A cases were not clinically relevant and not a target for treatment, we only considered grade B or C cases in this study. Patients with grades B or C PPH were at risk for death, and blood transfusion, angiography, embolization, relaparotomy, and intensive treatment in the intensive care unit were needed to improve the condition of these patients.

Diabetes mellitus {#Sec5}
-----------------

HbA1c level ≥ 6.3% was defined as DM in this study because the normal value of HbA1c in Japan is determined to be ≤ 6.2%.

Surgical policy {#Sec6}
---------------

Pancreatectomy with typical lymph node dissection for carcinoma involves regional lymph node dissection, and partial lymph node dissection was performed for inflammation and low malignant tumors. Regional lymph node dissection involves excision of the plexus in the right half of the SMA and dissection of the hepatoduodenal ligament from the left and right hepatic artery bifurcation to the upper margin of the pancreas. The reconstruction method was the Child's procedure. All patients underwent PJ anastomosis for gastroenterological reconstruction, and no patient underwent pancreatogastrostomy. Usually, the GDA stump was double ligated, and beginning in 2018, additional clipping (Hem-o-lok clip®; Telefrex Medical, USA) was performed on the GDA stump. Moreover, beginning in 2010, the GDA stump was wrapped with the falciform ligament. We performed duct-to-mucosa anastomosis for PJ until 2016 and modified Blumgart anastomosis after 2017. The surgeon chose PJ stenting if the diameter of the PJ anastomosis was narrow, reconstruction was difficult, and the remaining pancreas was soft.

Mortality rate {#Sec7}
--------------

The rate of inpatient death related to PPH during hospitalization was used as the mortality rate in this study.

Statistical analysis {#Sec8}
--------------------

Univariate and multivariate logistic regression analyses were performed to determine independent predictors of PPH in patients who had undergone pancreatectomy. Only factors that were significant on univariate analysis were subjected to multivariate analysis. A *P* value \< 0.05 was considered statistically significant. All the analyses were performed using JMP version 12.1.9 for Windows (SAS Institute Inc., Cary, NC, USA).

Results {#Sec9}
=======

Incidence, mortality, classification, reason, and treatment of PPH after all pancreatectomies (Table [1](#Tab1){ref-type="table"} {#Sec10}
---------------------------------------------------------------------------------------------------------------------------------

The incidence of PPH grades B or C was 3% in all 1169 patients undergoing pancreatectomy, 4% in the 675 patients undergoing PD, 1% in the 406 patients undergoing distal pancreatectomy (DP), and 3% in the 88 patients undergoing total pancreatectomy (TP). The incidence of late onset time, extraluminal location, high severity, bleeding from pseudoaneurysm, and interventional radiology treatment were 96%, 74%, 81%, 66%, and 63%, respectively. The median onset time of all PPH and bleeding from pseudoaneurysms from the initial surgery was 22 and 21 days, respectively. Mortality among patients with PPH was 11%. These patients died from multiple organ dysfunction caused by bleeding from pseudoaneurysms. The overall mortality rate within 30 and 90 days was 0.3% (3/1169) and 0.6% (7/1169), respectively. Mortality from PPH within 30 and 90 days was 0.2% (2/1169) and 0.3% (3/1169), respectively.Table 1Incidence, mortality, classification, reason, and treatment of post-pancreatectomy hemorrhage grades B or C after all pancreatectomyCategoryDefinitionAllPDDPTPTotal number of PPHs*n* = 35*n* = 27*n* = 5*n* = 3Incidence of PPH3% (35/1169)4% (27/675)1% (5/406)3% (3/88)Mortality among patients with PPH4 (11%)3 (11%)1 (20%)0 (0%)Median onset time from initial surgery (days), (range)22 (0--65)24 (0--47)9 (0--27)2 (0--65)Time of onsetEarly/late4 (4%)/31 (96%)1 (4%)/26 (96%)1 (20%)/4 (80%)2 (67%)/1 (33%)LocationIntraluminal/extraluminal9 (26%)/26 (74%)7 (26%)/20 (74%)1 (20%)/4 (80%)1 (33%)/2 (67%)SeverityMild/severe9 (19%)/26 (81%)5 (19%)/22 (81%)2 (40%)/3 (60%)2 (67%)/1 (33%)ReasonPseudoaneurysmGDA/HA/SMA/SPABleeding from the stump of the pancreas, greater omentum or retroperitoneal22 (66%)13/5/1/37 (19%)18 (66%)12/5/1/05 (19%)3 (60%)1/0/0/21 (20%)1 (33%)0/0/0/11 (33%)Gastrointestinal bleeding6 (15%)4 (15%)1 (20%)1 (33%)TreatmentInterventional radiologyConservative treatment with blood transfusionEndoscopic treatmentSurgeryInterventional radiology plus surgery19 (63%)6 (15%)5 (11%)4 (7%)1 (4%)17 (63%)4 (15%)3 (11%)2 (7%)1 (4%)2 (40%)1 (20%)1 (20%)1 (20%)0 (0%)0 (0%)1 (33%)1 (33%)1 (0%)0 (0%)*PPH* postpancreatectomy hemorrhage, *GDA* gastroduodenal artery, *HA* hepatic artery, *SMA* superior mesenteric artery, *SPA* splenic artery, *PD* pancreatoduodenectomy, *DP* distal pancreatectomy, *TP* total pancreatectomyClassification categories were defined by the International Study Group of Pancreatic Surgery \[[@CR7]\]Time of onset: early hemorrhage means that bleeding occurred ≤ 24 h after the end of the operation; late hemorrhage means that bleeding occurred \> 24 h after the end of the index operationLocation: intraluminal hemorrhage means bleeding from the gastrointestinal tract; extraluminal hemorrhage means bleeding from the abdominal cavitySeverity: Mild means that the patient's condition was not severe enough to necessitate invasive treatment; severe means that the patient's condition was poor, and it was necessary to perform intensive treatment

Univariate and multivariate analyses of risk factors for PPH after all pancreatectomies (Table [2](#Tab2){ref-type="table"}) and PPH rate by independent risk factors (Supplemental Table [2](#MOESM1){ref-type="media"}) {#Sec11}
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

In multivariate analysis, male sex (odds ratio \[OR\] 2.32), BMI ≥ 25 kg/m^2^ (OR 3.70), absence of DM (OR 3.62), and PD (OR 3.06) were significant independent risk factors for PPH in all patients undergoing pancreatectomy (*P* \< 0.05). When assessing using these risk factors, the incidence of PPH after all pancreatectomies in patients with a risk score of 0 (*n* = 65), 1 (*n* = 325), 2 (*n* = 455), 3 (*n* = 299), and 4 (*n* = 25) was 0%, 1%, 2%, 6%, and 20% (*P* \< 0.0001), respectively (Supplemental Table [2](#MOESM1){ref-type="media"}). The differences between risk-score groups 0--2 (2%) and 3--4 (7%) were significant (*P* \< 0.05, OR 4.7).Table 2Univariate and multivariate analyses of risk factors for post-pancreatectomy hemorrhage grades B or C after all pancreatectomyUnivariateMultivariateRisk factorsDefinition*n*PPHOR(95% CI)*P* valueOR(95% CI)*P* valueAge (years)\< 65≥ 6549367612 (2.4%)23 (3.4%)11.41 (0.70--2.87)0.34SexFemaleMale5186518 (1.5%)27 (4.2%)12.76 (1.24--6.12)0.001312.32 (1.02--5.26)0.034BMI (kg/m^2^)\< 25≥ 25101115824 (2.4%)11 (7.0%)13.08 (1.48--6.41)0.002713.70 (1.71--8.04)0.0009WBC (/ul)\< 8000≥ 80001093763 (4.0%)32 (2.9%)11.36 (0.41--4.56)0.62Alb (g/dl)≥ 3.5\< 3.5104012926 (2.5%)9 (7.0%)12.92 (1.34--6.39)0.007112.17 (0.95--4.98)0.066CRP (mg/dl)\< 1≥ 1105511429 (2.8%)6 (5.3%)11.97 (0.80--4.84)0.14DMPresenceAbsence4217486 (1.4%)29 (3.9%)12.79 (1.15--6.78)0.02313.62 (1.46--8.99)0.0056Pretreatment \*WithWithout3711321 (2.7%)34 (3.0%)11.11 (0.15--8.37)0.92Operative procedureDP4065 (1.2%)11PDTP6758827 (4.0%)3 (3.4%)3.34 (1.28--8.75)2.83 (0.66--12.1)0.0140.163.06 (1.12--8.36)3.27 (0.73--14.7)0.0290.12Operation time (min)\< 360≥ 36059757215 (2.5%)20 (3.5%)11.41 (0.71--2.77)0.33Blood loss (ml)\< 1200≥ 1200101015926 (2.6%)9 (5.7%)12.27 (1.04--4.94)0.03911.50 (0.66--3.43)0.34Vascular resectionWithout96729 (3.0%)10.98With2026 (3.0%)0.99 (0.41--2.42)\*Pretreatment was preoperative chemotherapy or chemoradiotherapy\*\*Delayed gastric emptying was defined by the International Study Group on Pancreatic Surgery*PPH* postpancreatectomy hemorrhage, *OR* odds ratio, *CI* confidence interval, *BMI* body mass index, *WBC* white blood cells, *Alb* albumin, *CRP* C-reactive protein, *DM* diabetes mellitus, *DP* distal pancreatectomy, *PD* pancreatoduodenectomy, *TP* total pancreatectomy, *DGE* delayed gastric emptying

Univariate and multivariate analyses of risk factors for PPH after PD (Table [3](#Tab3){ref-type="table"}) {#Sec12}
----------------------------------------------------------------------------------------------------------

Because PD was risk factor of PPH after all pancreatectomies, we evaluated risk factors for PPH after PD, excluding DP and TP. In multivariate analysis, POPF (OR 31.7) and absence of DM (OR 3.45) were independent risk factors for PPH after PD (*P* \< 0.05). There was no significant difference in the incidence of PPH between patients with and without falciform ligament wrapping of the GDA stump \[5.7% (11/276) and 2.8% (16/399), respectively; *P* = 0.059\]. The incidence of POPF after PD was 20%.Table 3Univariate and multivariate analyses of risk factors for postpancreatectomy hemorrhage grades B or C after pancreatoduodenectomyUnivariateMultivariateRisk factorsDefinition*n*PPHOR\
(95% CI)*P* valueOR\
(95% CI)*P* valuePeriod2005--20112012--20183243519 (2.8%)18 (5.1%)11.89 (0.84--4.27)0.12Age (years)\< 65≥ 652514248 (3.2%)19 (4.5%)11.43 (0.61--3.30)0.41SexFemaleMale2644117 (2.7%)20 (4.9%)11.88 (0.78--4.51)0.15BMI (kg/m^2^)\< 25≥ 255958020 (3.4%)7 (8.8%)12.76 (1.13--6.74)0.02112.22 (0.77--6.43)0.14WBC (/ul)\< 8000≥ 80006284725 (4.0%)2 (4.3%)11.07 (0.25--4.67)0.93Alb (g/dl)≥ 3.5\< 3.556311217 (3.0%)10 (8.9%)12.68 (1.17--6.12)0.01612.04 (0.79--5.28)0.14CRP (mg/dl)\< 1≥ 15779822 (3.8%)5 (5.1%)11.36 (0.50--3.67)0.56DMPresenceAbsence2414344 (1.7%)23 (5.3%)13.32 (1.13--9.70)0.02113.45 (1.06--11.3)0.040Pre-drainageWithoutWith40427113 (3.2%)14 (5.2%)11.64 (0.76--3.54)0.21Pretreatment \*WithWithout296461 (3.5%)26 (4.0%)11.17 '0.15--8.97)0.87Operation time (min)\< 360≥ 3602204559 (4.1%)18 (4.0%)1.04 (0.46--2.34)10.93Blood loss (ml)\< 1200≥ 120056610918 (3.2%)9 (8.4%)12.81 (1.23--6.43)0.01111.74 (0.65--4.66)0.27Vascular resectionWithoutWith56610922 (3.9%)5 (4.6%)11.19 (0.44--3.21)0.73PJ anastomosis methodDuct-to mucosaModified Blumgart5809523 (4.0%)4 (4.2%)11.06 (0.36--3.15)0.91Falciform ligament wrapping of GDA stumpWithoutWith39927616 (2.8%)11 (5.7%)12.13 (0.97--4.66)0.059Clipping of GDA stumpWithoutWith6571826 (4.0%)1 (5.6%)11.43 (0.18--11.1)0.75PJ stentWithoutWith3183578 (2.5%)19 (5.3%)12.18 (0.94--5.05)0.059Pathological tissue typePDACIPMNDEBDCPVCOthers26113914975506 (2.3%)3 (2.2%)12 (8.1%)4 (5.3%)2 (4.0%)110.94 (0.23--3.82)3.74 (1.37--10.2)2.40 (0.66--8.75)1.78 (0.35--9.07)0.930.0100.180.491.13 (0.22--5.72)1.49 (0.47--4.75)0.81 (0.19--3.49)2.14 (0.34--13.3)0.880.500.780.42POPF\*\*None or AB or C5421333 (0.6%)24 (18.1%)139.6 (11.8--133.7)\< 0.0001131.7 (8.94--112.2)\< 0.0001DGE\*\*\*None or AB or C6264925 (4.0%)2 (4.1%)11.02 (0.23--4.45)0.98Bile leakageWithoutWith6651026 (3.9%)1 (10.0%)12.73 (0.33--22.4)0.33\*Pretreatment was preoperative chemotherapy or chemoradiotherapy\*\*Postoperative pancreatic fistula was defined by the International Study Group on Pancreatic Surgery\*\*\*Postoperative delayed gastric emptying was defined by the International Study Group on Pancreatic Surgery*PPH* postpancreatectomy hemorrhage, *OR* odds ratio, *CI* confidence interval, *BMI* body mass index, *WBC* white blood cell, *Alb* albumin, *CRP* C-reactive protein, *DM* diabetes mellitus, *GDA* gastroduodenal artery, *PJ stent* pancreatojejunostomy stent, *PDAC* pancreatic ductal adenocarcinoma, *DEBDC* distal extrahepatic bile duct carcinoma, *IPMN* intraductal papillary mucinous neoplasm, *PVC* carcinoma of the papilla of Vater, *POPF* postoperative pancreatic fistula, *DGE* delayed gastric emptying

Univariate and multivariate analyses of risk factors for POPF after PD (Table [4](#Tab4){ref-type="table"}) {#Sec13}
-----------------------------------------------------------------------------------------------------------

Because POPF was risk factor for PPH after PD, we assessed risk factors for POPF after PD. In multivariate analysis, BMI ≥ 25 kg/m^2^ (OR 3.17), Alb \< 3.5 g/dl (OR 1.77), absence of DM (OR 1.75), distal extrahepatic bile duct carcinoma (OR 4.05), and carcinoma of the papilla of Vater (PVC) (OR 5.19) were independent risk factors for POPF after PD.Table 4Univariate and multivariate analyses of preoperative risk factors for postoperative pancreatic fistula grades B or C after pancreatoduodenectomyUnivariateMultivariateRisk factorsDefinition*n*POPFOR\
(95% CI)*P* valueOR\
(95% CI)*P* valueAge (years)\< 65≥ 6525142442 (16.8%)91 (21.5%)11.36 (0.91--2.04)0.14GenderFemaleMale26441137 (14.0%)96 (23.4%)11.87 (1.23--2.83)0.002411.57 (0.99--2.46)0.05002BMI (kg/m^2^)\< 25≥ 2559580106 (17.8%)27 (33.8%)12.35 (1.41--3.91)0.001513.17 (1.81--5.56)\< 0.0001WBC (/ul)\< 8000≥ 800062847120 (19.1%)13 (27.7%)11.62 (0.83--3.16)0.16Alb (g/dl)≥ 3.5\< 3.556311299 (17.6%)34 (30.4%)11.93 (1.22--3.06)0.005011.77 (1.07--2.93)0.027CRP (mg/dl)\< 1≥ 157798108 (18.7%)25 (25.5%)11.49 (0.90--2.45)0.12DMPresenceAbsence24143435 (14.5%)98 (22.6%)11.72 (1.12--2.62)0.012311.75 (1.10--2.78)0.019Pre-drainageWithoutWith40427165 (16.1%)68 (25.1%)11.75 (1.19--2.56)0.004210.69 (0.40--1.17)0.17Pretreatment \*WithWithout64629126 (19.5%)7 (24.1%)11.31 (0.55--3.14)0.54Pathological tissue typePDACIPMNDEBDCPVCOthers262139149755030 (11.5%)18 (13.0%)49 (32.9%)29 (38.7%)7 (14.0%)111.15 (0.62--2.15)3.79 (2.27--6.32)4.88 (2.67--8.89)1.26 (0.52--3.05)0.66\< 0.0001\< 0.00010.611.14 (0.60--2.20)4.05 (2.15--7.62)5.19 (2.70--9.97)1.05 (0.42--2.65)0.69\< 0.0001\< 0.00010.92\*Pretreatment was preoperative chemotherapy or chemoradiotherapy*POPF* postoperative pancreatic fistula, *OR* odds ratio, *CI* confidence interval, *BMI* body mass index, *WBC* white blood cell, A*lb* albumin, *CRP* c-reactive protein, *DM* diabetes mellitus, *PJ stent* pancreatojejunostomy stent, *PDAC* pancreatic ductal adenocarcinoma, *DEBDC* distal extrahepatic bile duct carcinoma, *IPMN* intraductal papillary mucinous neoplasm, *PVC* carcinoma of the papilla of Vater

Association between POPF and PPH after DP and PD {#Sec14}
------------------------------------------------

The incidence of POPF after DP was 19% (78/406). There was no significant difference in the incidence of POPF between DP and PD \[20% (133/675), *P* = 0.84\]. Unlike with PD where the OR of 31.7, there was also no significant association between POPF and PPH after DP \[3% (2/78) in patients with POPF and 1% (3/328) in patients without POPF; *P* = 0.28\].

Discussion {#Sec15}
==========

This study indicates that absence of DM (HbA1c level ≤ 6.2%) is an independent risk factor for PPH after all pancreatectomies and PD and for POPF after PD; a risk scoring system including the absence of DM may be useful for predicting PPH before surgery. By determining the value of HbA1c level (≤ 6.2%), we can predict PPH more easily. This is a new finding that has not been reported before.

In recent years, PPH has a low frequency, but it has a poor outcome. POPF, DGE, wound infection, and abdominal abscess are major complications of PD \[[@CR3], [@CR4], [@CR17]\]. Previous literatures reported that the incidence of PPH was only 3--16%; however, mortality among patients with PPH was 16--36% \[[@CR4]--[@CR12]\]. In this study, the incidence and mortality rates of patients with PPH were 3% (35/1169) and 11% (4/35), respectively (Table [1](#Tab1){ref-type="table"}), after all pancreatectomies. PPH was the major cause of death within 30 days after pancreatectomy. Previous literatures also reported that short-term outcomes after pancreatectomy were better in high-volume centers than in low-volume centers (mortality rate 0.9--6.0% vs. 13.0--18.8%) \[[@CR9], [@CR18]--[@CR20]\].

Some previous reports about intraoperative and postoperative factors showed that vascular resection, pancreaticogastrostomy, postoperative bile leakage, postoperative abdominal infection, and especially POPF were independent risk factors for PPH \[[@CR5]--[@CR12]\]. PPH from a pseudoaneurysm of the GDA stump usually results from POPF \[[@CR9], [@CR21]\], and the median onset time of PPH was reported as 5--13 days (range 0--58 days) \[[@CR6], [@CR10], [@CR12]\]. In our study, similar results were noted, and it is necessary to pay attention to the onset time from initial surgery (median onset time 22 days, range 0--65 days; Table [1](#Tab1){ref-type="table"}). Previous literatures have mentioned preoperative risk factors for PPH such as male sex, high BMI, and low Alb level \[[@CR8], [@CR10], [@CR12], [@CR14]\]; our study also showed a similar result. Additionally, in our study, "absence of DM (HbA1c level ≤ 6.2%)" was one of the significant independent risk factors for PPH after all pancreatectomies and PD, which has not been reported.

Insulin acts to promote secretion of pancreatic exocrine cells \[[@CR22]\]. It has been reported that the pancreatic exocrine function declined as insulin secretion decreased and the exocrine pancreatic glands atrophied \[[@CR23]\]. This means that in patients with DM, the pancreatic parenchyma atrophies and becomes hard, and in patients without DM, the pancreatic parenchyma is thick and soft. Traditionally, patients with a soft pancreas, thick parenchyma, and thin pancreatic duct are considered at risk for POPF after PD \[[@CR24]--[@CR27]\]. Pancreatic exocrine function is an important determinant of POPF after PD \[[@CR28]\]. In pancreatic carcinoma, it has been reported that pancreatic parenchyma atrophy is seen from the onset of illness and the main pancreatic duct is dilated \[[@CR29]\]. In the same way, in a patient with intraductal papillary mucinous neoplasm, the main pancreatic duct is slightly dilated and the pancreatic parenchyma is relatively decreased and atrophic. In contrast, in patients with distal extrahepatic bile duct carcinoma, main pancreatic duct dilation and pancreatic parenchyma atrophy are rare. Patients with a thick and soft pancreatic parenchyma have a high possibility of POPF and a high risk of PPH after pancreatectomy. In situations where there is no clear definition of the thickness and hardness of the pancreas and it is difficult to judge them preoperatively, the presence or absence of DM (HbA1c level ≤ 6.2%) is considered to be one of the good indicators.

Previous literatures reported that omental flaps or grafts around various anastomoses after PD could reduce the incidence of POPF and PPH \[[@CR30], [@CR31]\]. In this study, the statistical analysis did not show a significant benefit of wrapping the GDA stump for preventing PPH. We believe we cannot draw sufficient statistical conclusions because of differences in surgical techniques and instruments, differences in applications and methods of round ligament wrapping, and the limited use of clips in recent cases. Hence, further clinical evaluation for this is necessary. In addition, pancreatic surgery in patients at high risk for developing PPH may require new precautions to further reduce the incidence of PPH.

Limitations {#Sec16}
-----------

Patients from different periods over the 14-year span of the study underwent different diagnostic and treatment modalities owing to the advances in techniques that occurred over time; these variations may have skewed the outcomes of patients treated during the different periods of the study. Moreover, our investigation had a retrospective design and was performed at a single institution; the biases inherent in such settings cannot be completely excluded.

Conclusion {#Sec17}
==========

Male sex, BMI ≥ 25 kg/m^2^, absence of DM (HbA1c level ≤ 6.2%), and PD are independent risk factors for PPH after all pancreatectomies. A risk scoring system including the new preoperative risk factor "absence of DM" would be useful for predicting PPH.
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